In the current global oncology landscape, solid tumors comprise over 70% of all cancer cases. They are responsible for the majority of cancer-related ...

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...

The document outlines the non-clinical sequencing and bioinformatics data sponsors need to submit as part of INDs and BLAs for gene-editing therapies.

The document outlines the non-clinical sequencing and bioinformatics data sponsors need to submit as part of INDs and BLAs for gene-editing therapies.

GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for ...

Automating NGS sample preparation to accelerate microbiome research Microbiome research often involves complex workflows and ...

MGI Tech marks a decade of progress in genomics, highlighting key technology milestones that have accelerated life science ...

Generation Sequencing Market by Product Type, Technology, Workflow, Services, Application - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The next-generation sequencing ...

Agilent Technologies and BaseSolve announce a co-marketing agreement to offer a U.S.-focused integrated solution for NGS workflows. This collaboration provides a streamlined genomics workflow by ...

Microbiology laboratories face competing demands to deliver rapid, accurate results while managing rising caseloads and ...

Across tumor types, 1-year NGS uptake rose substantially from 2018 to 2022, reaching 74.5% in aNSCLC and 78.1% in mCRC, but ...

Learn more about whether Relay Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ ...